The global Membrane Chromatography Market is transforming the way pharmaceutical companies purify biologics. With rising demand for vaccines, biosimilars, and monoclonal antibodies, purification technologies are more important than ever.
As reported in the Membrane Chromatography Market, rapid biopharmaceutical expansion is driving adoption worldwide. The technique offers high flow rates, scalability, and cost efficiency compared to conventional column chromatography.
Biopharma companies prefer membrane chromatography for its flexibility and faster turnaround time. It is especially useful in downstream processing during vaccine manufacturing. The COVID-19 pandemic further accelerated investments in this segment.
Research institutes and contract manufacturing organizations (CMOs) are also increasing usage. As more biologic drugs enter clinical trials, demand for advanced purification methods will keep rising.
❓ FAQs
Q1: What drives the global market?
Rising biologics production and vaccine demand.
Q2: Is membrane chromatography better than traditional methods?
It is faster and more scalable for many applications.
Q3: Which industries use it most?
Biopharma and biotech industries primarily.
Browse More Reports:
Transient Protein Expression Market
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt